Anastasia Henry

Title: Innovations of Anastasia Henry

Introduction

Anastasia Henry is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins and methods for treating various disorders. With a total of three patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Anastasia's latest patents include innovative solutions such as fusion proteins comprising enzyme replacement therapy enzymes. These fusion proteins are designed to treat lysosomal storage disorders by combining an enzyme replacement therapy enzyme with an Fc region. Additionally, she has developed methods for transporting agents across the blood-brain barrier, which is crucial for delivering treatments to the central nervous system. Another notable patent involves phospho-Rab antibodies, which specifically bind to phosphorylated Rab proteins. This includes monoclonal antibodies that target human Rab10 and Rab8a proteins, providing new avenues for research and diagnostics.

Career Highlights

Anastasia Henry is currently associated with Denali Therapeutics Inc., a company focused on developing therapies for neurodegenerative diseases. Her work at Denali has been instrumental in advancing the understanding and treatment of complex medical conditions.

Collaborations

Anastasia collaborates with esteemed colleagues such as Mihalis S Kariolis and Cathal S Mahon. Their combined expertise enhances the innovative research and development efforts at Denali Therapeutics Inc.

Conclusion

Anastasia Henry's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical therapies and treatments.